May 11, 2023
The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).
On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.
“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.”
April 24, 2025
The Senate health and human services omnibus bill, which includes several of the MMA’s legislative priorities, was heard in the Taxes Committee on April 23. It also includes an increase in the provider tax from 1.8% to 2%.
April 24, 2025
At a press event on April 21, Republican leaders proposed limiting access to MinnesotaCare for undocumented Minnesotans.
April 24, 2025
More than a year after the cyberattack at Change Healthcare, a UnitedHealth Group (UHG) subsidiary, some Minnesota practices are still suffering from cashflow issues.